GATC Health and Vistagen Partner on Predictive Drug Development
1 report, 1 independent
Updated Oct 20
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GATC Health and Vistagen have collaborated to integrate predictive modeling with neuroscience for drug discovery. GATC Health is providing its Operon® platform and Derisq® report to Vistagen’s clinical programs. This collaboration supports Vistagen’s potential Phase 3 study of fasedienol for social anxiety disorder, as well as potential Phase 2 studies of itruvone and refisolone.
From manilatimes.net
Why it matters
The partnership uses artificial intelligence and neuroscience to provide strategic insights for drug development. This helps guide protocol design, prioritize the company's pipeline, and allocate resources for clinical trials.
Vistagen is a late-stage biopharma company that is developing a new product.
From manilatimes.net